Hutch News

Hutch News

Stories tagged 'lobular breast cancer'

Metastatic breast cancer research takes the stage

Advocates, oncologists and researchers share findings, resources and reasons for hope at third annual NW Mets Conference

Oct. 31, 2018 | By Diane Mapes / Fred Hutch News Service

An overview of the third annual Northwest Metastatic and Lobular Breast Cancer Conference, held Oct. 26-27 in Seattle.

View story >


Lobular breast cancer comes into the spotlight

Research collaborations, patient advocates push to explore ‘sneaky,’ understudied subtype’s standing as a distinct disease

Feb. 15, 2018 | By Diane Mapes / Fred Hutch News Service

Lobular breast cancer is the sixth most common cancer in women yet many people have never heard of it. It doesn't image well, may not create a lump and is considered to be an "understudied" cancer. That's changing. Fred Hutch researchers and patient advocates break it down.

View story >


Metastatic breast cancer patients gather in Seattle

300 patients, advocates and researchers talk science, health disparities and filling in crucial data gaps at 'mets' conference

Sept. 26, 2017 | By Diane Mapes / Fred Hutch News Service

More than 300 metastatic breast cancer patients, researchers, advocates and caregivers gathered in Seattle over the weekend to discuss promising new therapies, patient-researcher partnerships, big data, advocacy, and, yes, cures.

View story >


Understanding Rita Wilson's diagnosis

Oncologist Dr. V.K. Gadi explains the actress's type of breast cancer: lobular carcinoma in situ

April 15, 2015 | By Dr. V.K. Gadi / For Seattle Cancer Care Alliance

Oncologist Dr. V.K. Gadi explains the actress's type of breast cancer: lobular carcinoma in situ

View story >


Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers

Jan. 7, 2008 | By Kristen Woodward

Dr. Christopher Li and colleagues in Fred Hutchinson Cancer Research Center found that postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.